These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30468523)

  • 1. Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity.
    Goksen US; Sarigul S; Bultinck P; Herrebout W; Dogan I; Yelekci K; Ucar G; Gokhan Kelekci N
    Chirality; 2019 Jan; 31(1):21-33. PubMed ID: 30468523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
    Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric synthesis, molecular modeling and biological evaluation of 5-methyl-3-aryloxazolidine-2,4-dione enantiomers as monoamine oxidase (MAO) inhibitors.
    Erol Gunal S; Teke Tuncel S; Gokhan Kelekci N; Ucar G; Yuce Dursun B; Sag Erdem S; Dogan I
    Bioorg Chem; 2018 Apr; 77():608-618. PubMed ID: 29501028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues.
    Evranos-Aksoz B; Ucar G; Yelekci K
    Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
    Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
    Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
    Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
    J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Cirilli R; La Torre F; Alcaro S; Ortuso F; Langer T
    Curr Med Chem; 2006; 13(12):1411-28. PubMed ID: 16719786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
    Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
    Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.
    Evranos-Aksöz B; Baysal İ; Yabanoğlu-Çiftçi S; Djikic T; Yelekçi K; Uçar G; Ertan R
    Arch Pharm (Weinheim); 2015 Oct; 348(10):743-56. PubMed ID: 26293971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.
    Tong X; Chen R; Zhang TT; Han Y; Tang WJ; Liu XH
    Bioorg Med Chem; 2015 Feb; 23(3):515-25. PubMed ID: 25541201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, Docking Studies and Monoamine Oxidase Inhibition of a Small Library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles.
    Guglielmi P; Carradori S; Poli G; Secci D; Cirilli R; Rotondi G; Chimenti P; Petzer A; Petzer JP
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30700029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
    Hitge R; Smit S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
    Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M
    Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.
    Cirilli R; Ferretti R; Gallinella B; Turchetto L; Bolasco A; Secci D; Chimenti P; Pierini M; Fares V; Befani O; La Torre F
    Chirality; 2004 Nov; 16(9):625-36. PubMed ID: 15382204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
    Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
    Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.